Skip to main content
      Time the💉
      Response to pneumococcal vaccine better when given before starting MTX.

      Stay updated on ACR and EULAR vac

      Jiha Lee JihaRheum

      1 month ago
      Time the💉 Response to pneumococcal vaccine better when given before starting MTX. Stay updated on ACR and EULAR vaccination recommendations! #ACR24 @RheumNow ABST#2676
      How long before starting MTX should pts receive PCV13 vaccine?
      ➡️In RA, PCV13 vaccine given 1 month before starting

      Mrinalini Dey DrMiniDey

      1 month ago
      How long before starting MTX should pts receive PCV13 vaccine? ➡️In RA, PCV13 vaccine given 1 month before starting MTX led to significantly higher immunological response at 1 month compared to pts vaccinated on MTX ⏩Vaccinate pts before starting MTX Ab2676 #ACR24 @RheumNow
      Abstract 2681: #SDOH factors & SLE risk:

      - Low income (AOR=2.779).
      - By race/ethnicity NHB (AOR=2.429), Hispanic (A

      Akhil Sood MD AkhilSoodMD

      1 month ago
      Abstract 2681: #SDOH factors & SLE risk: - Low income (AOR=2.779). - By race/ethnicity NHB (AOR=2.429), Hispanic (AOR=1.616). Behavioral: Psych distress (AOR=2.127), no exercise (AOR=1.677). Access: Medicaid (AOR=2.540), transport barriers (AOR=20.394). @RheumNow #ACR24
      For daily recaps, content and updates from #ACR24 head to https://t.co/eL0bMhnFiu @RheumNow with input from colleagues i

      Antoni Chan MD (Prof) synovialjoints

      1 month ago
      For daily recaps, content and updates from #ACR24 head to https://t.co/eL0bMhnFiu @RheumNow with input from colleagues in the faculty @synovialjoints @bella_mehta @ericdeinmd @AkhilSoodMD. @DrMiniDey @CaoilfhionnMD @ebrhuem @rheumarampa @Dr_Brian_MD @AdelaCastro222 @JihaRheum… https://t.co/a3FQjGokhn https://t.co/1g3Fi01HWG
      #Ianalumab
      300 mg sc q monthly

      B cell depleted and changes BAFF signalling

      👇⬇️IFN

      May be promising in #lupu

      Janet Pope Janetbirdope

      1 month ago
      #Ianalumab 300 mg sc q monthly B cell depleted and changes BAFF signalling 👇⬇️IFN May be promising in #lupus #SLE +data in primary #Sjogrens ACR24 @RheumNow @ACRheum Abst#2425 Needs Phase3 ➡️I suspect safer than CAR T and Bispecific T cell engagers but ? ⬇️efficacy
      ACR24 take homes

      ➡️#Inflammatory #myositis
      #Upadacitinib improved MDA5 ILD
      #Baricitinib 4mg/d good in myositis de

      Janet Pope Janetbirdope

      1 month ago
      ACR24 take homes ➡️#Inflammatory #myositis #Upadacitinib improved MDA5 ILD #Baricitinib 4mg/d good in myositis delayed start #RCT #Tofacitinb ➡️help for skin, calcinosis, rash in case series ➡️RCT ongoing JAKi is ‘jacked’ in muscles 💪🏿 #ACR24 @RheumNow @ACRheum 1731 0348
      Biggest absence award at #ACR24 @ACRheum @RheumNow
      🥇

      Absence of discussion on
      👇
      #Oral #Surveillance

      Except fo

      Janet Pope Janetbirdope

      1 month ago
      Biggest absence award at #ACR24 @ACRheum @RheumNow 🥇 Absence of discussion on 👇 #Oral #Surveillance Except for maybe Monitoring for mouth ulcers and cancers issues are not resolved but we are comfortable with ambiguity!
      Taking CAR-T for a Test Drive

      What is CAR-T? How can you get a healthy dose of it at #ACR24? And what does it mean for

      Dr. John Cush RheumNow

      1 month ago
      Taking CAR-T for a Test Drive What is CAR-T? How can you get a healthy dose of it at #ACR24? And what does it mean for the future? Read on to find out! https://t.co/TnNHzWQndp https://t.co/qWgwjiEdLF
      Different factors are known to influence disease characteristics and outcomes in psoriatic arthritis (PsA). Recently, there is new evidence that sex-related differences play a role not only in disease manifestations but also in efficacy and safety of treatments as well as outcomes and prognosis.
      Are Emulation Trials a Fantasy?

      Are these ‘trials’ helpful, despite the biases that occur with observational data,

      Dr. John Cush RheumNow

      1 month ago
      Are Emulation Trials a Fantasy? Are these ‘trials’ helpful, despite the biases that occur with observational data, or do they truly mimic the results of randomized controlled trials (RCTs)? https://t.co/x6NogGQksW https://t.co/f8o8N55tlJ
      axSpA: Moving the needle in time to diagnosis

      The journey to axial spondyloarthritis (axSpA) diagnosis is often prolong

      Dr. John Cush RheumNow

      1 month ago
      axSpA: Moving the needle in time to diagnosis The journey to axial spondyloarthritis (axSpA) diagnosis is often prolonged and challenging. Understanding the factors contributing to the delays is important to improve the clinical, psychological, social and economic outcomes.… https://t.co/wnwtj8jj0q https://t.co/Pds2uxVfJV
      ×